Viewing Study NCT01294293

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:05 AM
Ignite Modification Date: 2026-01-03 @ 10:32 AM
Study NCT ID: NCT01294293
Status: COMPLETED
Last Update Posted: 2014-12-25
First Post: 2011-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
Sponsor: Gynecologic Oncology Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignant Ovarian Mixed Epithelial Tumor View
None Ovarian Brenner Tumor View
None Ovarian Clear Cell Cystadenocarcinoma View
None Ovarian Endometrioid Adenocarcinoma View
None Ovarian Mucinous Cystadenocarcinoma View
None Ovarian Serous Cystadenocarcinoma View
None Recurrent Fallopian Tube Carcinoma View
None Recurrent Ovarian Carcinoma View
None Recurrent Primary Peritoneal Carcinoma View
None Undifferentiated Ovarian Carcinoma View
Keywords: